CUBRC, INC. - DEVELOPING UNIVERSAL CONTROL PEPTIDES FOR T-CELL ASSAYS SUPPORTING IMMUNOGENICITY

On Jan 15, 2026, Department of Health and Human Services obligated $1,255,735 to CUBRC, INC. for developing universal control peptides for t-cell assays supporting immunogenicity. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in BUFFALO, NY. The contract is scheduled through Sep 30, 2026 — approximately 6 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.